Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma November 16, 2017 Merck KGaA to Shutter Four Sites, Lay Off 200 Employees July 12, 2017 Infinity Pharma And Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 In Combination With Opdivo (Nivolumab) September 24, 2017
Infinity Pharma And Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 In Combination With Opdivo (Nivolumab) September 24, 2017
